Related Experiment Video
Updated: May 22, 2025

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
Published on: October 18, 2024
Obesity Management Medications as Adjuncts to Metabolic and Bariatric Surgery: Consensus Recommendations from India
Ramen Goel1, Nandakishore Dukkipati2, Randeep Wadhawan3
1Wockhardt Hospital, Mumbai Central, Mumbai, India. ramengoel@gmail.com.
Abstract:
Obesity is a global health concern, with weight regain (WR) common after bariatric surgery. Clear guidelines on post-surgical medication use are essential. This expert consensus evaluates the role of obesity management medications (OMMs) in optimizing weight loss (WL) and preventing WR in individuals undergoing metabolic and bariatric surgery (MBS). Using a modified Delphi approach, a panel of 12 experts reviewed evidence and formulated consensus recommendations. Two voting rounds led to consensus on 11 of 15 statements, covering preoperative WL strategies and postoperative weight management. The recommendations guide OMM selection, timing, and effectiveness in enhancing WL outcomes. Integrating OMMs into bariatric care protocols can help clinicians improve long-term success rates in obesity management.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hormonal Regulation
Obesity
Antidepressant Drugs: MAOIs and Other Agents
Lipid-Lowering Drugs: Statins and Miscellaneous Agents

